Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry

Oral Oncology

Volumn 41, Issue 2, 2005, Pages 183-199

  Baker, Haven ^a   Patel, Vyomesh ^b   Molinolo, Alfredo A ^b   Shillitoe, Edward J ^c   Ensley, John F ^d   Yoo, George H ^d   Meneses García, Abelardo ^e   Myers, Jeffrey N ^f   El Naggar, Adel K ^f   Gutkind, J Silvio ^b   Hancock, William S ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biomarkers; Drug targets; Mass spectrometry; Microdissection; Oral cancer; Proteome

Indexed keywords

CYTOKERATIN 13; HEAT SHOCK PROTEIN 90; PLACENTAL GROWTH FACTOR; PROTEOME; TRYPSIN; UNCLASSIFIED DRUG; WNT 14 PROTEIN; WNT 6 PROTEIN; WNT PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; HEAD CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; MALE; NECK CANCER; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; SOLUBILIZATION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STAINING; TANDEM MASS SPECTROMETRY; TUMOR CELL;

AGED; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, LIQUID; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LASERS; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; PROTEOME; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 20844437570     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.08.009     Document Type: Article

References (46)

1. A. Jemal, R.C. Tiwari, and T. Murray Cancer statistics CA Cancer J. Clin. 54 1 2004 8 29
2. M.N. Shiu, and T.H. Chen Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer Eur. J. Cancer Prev. 13 1 2004 39 45
3. P.K. Ha, N.E. Benoit, and R. Yochem A transcriptional progression model for head and neck cancer Clin. Cancer Res. 9 8 2003 3058 3064
4. O. Bettendorf, J. Piffko, and A. Bankfalvi Prognostic and predictive factors in oral squamous cell cancer: Important tools for planning individual therapy? Oral Oncol. 40 2 2004 110 119
5. B.W. Neville, and T.A. Day Oral cancer and precancerous lesions CA Cancer J. Clin. 52 4 2002 195 215
6. A. Bankfalvi, and J. Piffko Prognostic and predictive factors in oral cancer: The role of the invasive tumour front J. Oral Pathol. Med. 29 7 2000 291 298
7. I. Alevizos, M. Mahadevappa, and X. Zhang Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis Oncogene 20 43 2001 6196 6204
8. R.L. Strausberg, S.F. Greenhut, L.H. Grouse, C.F. Schaefer, and K.H. Buetow In silico analysis of cancer through the Cancer Genome Anatomy Project Trends Cell Biol. 11 11 2001 S66 S71
9. C. Leethanakul, V. Knezevic, and V. Patel Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis Oral Oncol. 39 3 2003 248 258
10. V.C. Wasinger, and G.L. Corthals Proteomic tools for biomedicine J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 771 1-2 2002 33 48
11. S.E. Ong, and A. Pandey An evaluation of the use of two-dimensional gel electrophoresis in proteomics Biomol. Eng. 18 5 2001 195 205
12. A. Sickmann, M. Mreyen, and H.E. Meyer Mass spectrometry-a key technology in proteome research Adv. Biochem. Eng. Biotechnol. 83 2003 141 176
13. W.M. Bodnar, R.K. Blackburn, J.M. Krise, and M.A. Moseley Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage J. Am. Soc. Mass Spectrom. 14 9 2003 971 979
14. N.L. Simone, R.F. Bonner, J.W. Gillespie, M.R. Emmert-Buck, and L.A. Liotta Laser-capture microdissection: opening the microscopic frontier to molecular analysis Trends Genet. 14 7 1998 272 276
15. S.L. Wu, W.S. Hancock, G.G. Goodrich, and S.T. Kunitake An approach to the proteomic analysis of a breast cancer cell line (SKBR-3) Proteomics 3 6 2003 1037 1046
16. S. Zhang, C.K. Van Pelt, and J.D. Henion Automated chip-based nanoelectrospray-mass spectrometry for rapid identification of proteins separated by two-dimensional gel electrophoresis Electrophoresis 24 21 2003 3620 3632
17. D.C. Anderson, W. Li, D.G. Payan, and W.S. Noble A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: support vector machine classification of peptide MS/MS spectra and SEQUEST scores J. Proteome Res. 2 2 2003 137 146
18. A. Lamaroon, K. Pattanaporn, and S. Pongsiriwet Analysis of 587 cases of oral squamous cell carcinoma in northern Thailand with a focus on young people Int. J. Oral Maxillofac Surg. 33 1 2004 84 88
19. C. Leethanakul, V. Patel, and J. Gillespie Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays Oncogene 19 28 2000 3220 3224
20. S.L. Wu, H. Amato, R. Biringer, G. Choudhary, P. Shieh, and W.S. Hancock Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system J. Proteome Res. 1 5 2002 459 465
21. P. Chaurand, S.A. Schwartz, and R.M. Caprioli Assessing protein patterns in disease using imaging mass spectrometry J. Proteome Res. 3 2 2004 245 252
22. J. Peng, and S.P. Gygi Proteomics: the move to mixtures J. Mass Spectrom. 36 10 2001 1083 1091
23. J.G. Glanzer, and J.H. Eberwine Expression profiling of small cellular samples in cancer: less is more Br. J. Cancer 90 6 2004 1111 1114
24. D.P.T. Li Zang, W.S. Hancock, D.C. Sgroi, and B.L. Karger Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling J. Proteome. Res. 3 3 2004 604 612
25. F.X. Real, M.R. Vila, A. Skoudy, F.C. Ramaekers, and J.M. Corominas Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer Int. J. Cancer 54 5 1993 720 727
26. M. Morifuji, S. Taniguchi, H. Sakai, Y. Nakabeppu, and M. Ohishi Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability Am J. Pathol. 156 4 2000 1317 1326
27. S. Prasad, P. Thraves, A. Dritschilo, and M. Kuettel Expression of cytokeratin-19 as a marker of neoplastic progression of human prostate epithelial cells Prostate 35 3 1998 203 211
28. A. Leunig, C.S. Betz, and M. Mehlmann Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence Laryngoscope 110 1 2000 78 83
29. Q.Y. He, J. Chen, H.F. Kung, A.P. Yuen, and J.F. Chiu Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics Proteomics 4 1 2004 271 278
30. J. Kaur, A. Srivastava, and R. Ralhan Expression of 70 kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity Oral Oncol. 34 6 1998 496 501
31. E. Schmitt, A. Parcellier, and S. Gurbuxani Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant Cancer Res. 63 23 2003 8233 8240
32. P.A. Townsend, R.I. Cutress, A. Sharp, M. Brimmell, and G. Packham BAG-1: a multifunctional regulator of cell growth and survival Biochim. Biophys. Acta 1603 2 2003 83 98
33. T. Kleinjung, O. Arndt, and H.J. Feldmann Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy-a target for natural killer (NK) cells Int J. Radiat. Oncol. Biol. Phys. 57 3 2003 820 826
34. L. Neckers, and S.P. Ivy Heat shock protein 90 Curr. Opin. Oncol. 15 6 2003 419 424
35. L. Neckers Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identification Curr. Med. Chem. 10 9 2003 733 739
36. D.B. Solit, A.D. Basso, A.B. Olshen, H.I. Scher, and N. Rosen Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol Cancer Res. 63 9 2003 2139 2144
37. P. Amornphimoltham, V. Sriuranpong, V. Patel, F. Benavides, C.J. Conti, and J. Sauk Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01 Clin. Cancer Res. 10 12 2004 4029 4037
38. C.S. Rhee, M. Sen, and D. Lu Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas Oncogene 21 43 2002 6598 6605
39. M. Uraguchi, M. Morikawa, M. Shirakawa, K. Sanada, and K. Imai Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity J. Dent Res. 83 4 2004 327 332
40. F.R. Schubert, R.C. Mootoosamy, and E.H. Walters Wnt6 marks sites of epithelial transformations in the chick embryo Mech. Dev. 114 1-2 2002 143 148
41. H. Kirikoshi, H. Sekihara, and M. Katoh WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly coexpressed in SW480 cells Biochem. Biophys Res. Commun. 283 4 2001 798 805
42. C. Hartmann, and C.J. Tabin Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton Cell 104 3 2001 341 351
43. H. Kirikoshi, H. Sekihara, and M. Katoh Molecular cloning and characterization of WNT14B, a novel member of the WNT gene family Int. J. Oncol. 19 5 2001 947 952
44. M. Autiero, A. Luttun, M. Tjwa, and P. Carmeliet Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders J. Thromb. Haemost. 1 7 2003 1356 1370
45. K. Matsumoto, K. Suzuki, and H. Koike Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels Anticancer Res. 23 6D 2003 4953 4958
46. F. Larcher, M. Franco, and M. Bolontrade Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angioprotein expression in mouse skin carcinogenesis Mol. Carcinog. 37 2 2003 83 90